(Q40092703)

17 September 2017

1 reference

title

Clinical applications of slow channel blocking compounds (English)

1 reference

17 September 2017

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

13 August 2023

author name string

A. G. Ellrodt

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6140691

13 August 2023

B. N. Singh

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6140691

13 August 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6140691

13 August 2023

publication date

1 January 1983

1 reference

full work available at URL

17 September 2017

https://api.elsevier.com/content/article/PII:0163725883900256?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

https://api.elsevier.com/content/article/PII:0163725883900256?httpAccept=text/plain

13 August 2023

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Pharmacology & Therapeutics

13 August 2023

published in

1 reference

17 September 2017

23

1 reference

17 September 2017

1-43

1 reference

17 September 2017

1

1 reference

Cerebral Arterial Spasm – A Controlled Trial of Nimodipine in Patients with Subarachnoid Hemorrhage

17 September 2017

2

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Cerebral arterial spasm: part 10. Reversal of acute and chronic spasm in dogs with orally administered nifedipine

13 August 2023

3

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Cerebral arterial spasm: part 9. In vitro effects of nifedipine on serotonin-, phenylephrine-, and potassium-induced contractions of canine basilar and femoral arteries

13 August 2023

4

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Nifedipine therapy for coronary-artery spasm. Experience in 127 patients

13 August 2023

5

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Calcium Channel Blocking Agents in the Treatment of Cardiovascular Disorders. Part I: Basic and Clinical Electrophysiologic Effects

13 August 2023

6

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

The Effect of Nifedipine on the Sinus and Atrioventricular Node of the Dog Heart after β-Adrenergic Receptor Blockade

13 August 2023

7

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Nifedipine and beta-blocker drugs.

13 August 2023

8

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Assessment of verapamil in the treatment of angina pectoris

13 August 2023

10

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Antihypertensive effect of cardiovascular Ca2+-antagonist in hypertensive patients in the absence and presence of beta-adrenergic blockade

13 August 2023

11

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Hypotensive action and increased plasma renin activity by Ca2+ antagonist (Nifedipine) in hypertensive patients

13 August 2023

12

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Verapamil in atrial fibrillation and atrial flutter

13 August 2023

13

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Haemodynamic effects of intravenous verapamil at rest and during exercise in subjectively healthy middle-aged men

13 August 2023

16

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Inotropic and electrophysiological actions of verapamil and D 600 in mammalian myocardium. III. Effects of the optical isomers on transmembrane action potentials

13 August 2023

19

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Efficacy of sublingual nifedipine in the acute treatment of systemic hypertension

13 August 2023

20

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

13 August 2023

Asystole after verapamil

22

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Beneficial effect of intravenous diltiazem in the acute management of paroxysmal supraventricular tachyarrhythmias

13 August 2023

23

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Sodium ions, calcium ions, blood pressure regulation, and hypertension: a reassessment and a hypothesis

13 August 2023

24

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Effects of verapamil and propranolol on left ventricular systolic function and diastolic filling in patients with coronary artery disease: radionuclide angiographic studies at rest and during exercise

13 August 2023

25

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Calcium-channel blockers: pharmacologic considerations

13 August 2023

27

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Effects of verapamil on sinus node function in man

13 August 2023

30

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Clinical experimental studies on the blood pressure reducing effect of verapamil

13 August 2023

31

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Hepatotoxicity due to treatment with verapamil

13 August 2023

32

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Treatment of stable angina of effort with verapamil: a double-blind, placebo-controlled randomized crossover study

13 August 2023

33

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Digoxin plasma concentrations and nifedipine

13 August 2023

34

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Primary pulmonary hypertension: effects of nifedipine

13 August 2023

36

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Effect of verapamil on normal sinoatrial node function and on sick sinus syndrome

13 August 2023

37

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Electro- and pharmacomechanical coupling in vascular smooth muscle

13 August 2023

38

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Effects of verapamil on coronary hemodynamic function and vasomobility relative to its mechanism of antianginal action.

13 August 2023

39

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Influence of severity of ventricular dysfunction on hemodynamic responses to intravenously administered verapamil in ischemic heart disease

13 August 2023

40

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Nifedipine: A myocardial protective agent

13 August 2023

42

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

The effects of diltiazem and reduced serum ionized calcium on ischemic ventricular fibrillation in the dog.

13 August 2023

45

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Effect of a calcium inhibitor, nifedipine, on exercise tolerance in patients with angina pectoris: a double-blind study.

13 August 2023

47

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Action potentials, afterpotentials, and arrhythmias

13 August 2023

49

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

The effects of nifedipine, a calcium antagonist, on platelet function

13 August 2023

51

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Effect of verapamil on regional coronary and myocardial perfusion during acute coronary occlusion

13 August 2023

52

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Role of calcium antagonists in cardiovascular therapy

13 August 2023

53

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Calcium antagonist drugs in chronic stable angina. Comparison of verapamil and nifedipine

13 August 2023

54

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Biological Membranes: The Physical Basis of Ion and Nonelectrolyte Selectivity

13 August 2023

57

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Antianginal efficiency of nifedipine with and without a beta-blocker, studied with exercise test. A double-blind, randomized subacute study

13 August 2023

61

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Cardiac electrophysiologic alterations during myocardial ischemia

13 August 2023

62

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Therapeutic implications of slow-channel blockade in cardiocirculatory disorders

13 August 2023

63

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Prinzmetal's variant form of angina pectoris. Re-evaluation of mechanisms

13 August 2023

64

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Calcium and Cardiac Excitation-Contraction Coupling

13 August 2023

65

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Effects of verapamil on ventricular premature beats of acute myocardial infarction

13 August 2023

66

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Short- and long-term responses to diltiazem in patients with variant angina

13 August 2023

67

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Effects of verapamil on myocardial performance in coronary disease

13 August 2023

68

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Left ventricular function in patients with coronary artery disease after verapamil administration

13 August 2023

69

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Antianginal and myocardial metabolic properties of verapamil in coronary artery disease

13 August 2023

70

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Mechanism of rest and nocturnal angina: observations during continuous hemodynamic and electrocardiographic monitoring

13 August 2023

71

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Specific Pharmacology of Calcium in Myocardium, Cardiac Pacemakers, and Vascular Smooth Muscle

13 August 2023

74

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

The use of propranolol and nifedipine in the medical management of angina pectoris

13 August 2023

78

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Electrophysiologic and hemodynamic actions of diltiazem: disparate temporal effects shown by experimental dose-response studies

13 August 2023

81

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Nifedipine in unstable angina: a double-blind, randomized trial

13 August 2023

83

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Verapamil-induced hyperprolactinemia and galactorrhea

13 August 2023

85

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Effect on paroxysmal re-entrant supraventricular tachycardia of a drug affecting calcium transport (Ro 11-1781)

13 August 2023

86

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Nifedipine in the treatment of prinzmetal's (variant) angina

13 August 2023

87

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Selective suppression of some components of spontaneous activity in various types of smooth muscle by iproveratril (Verapamil).

13 August 2023

88

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Treatment of supraventricular arrhythmias with intravenous and oral verapamil

13 August 2023

89

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Arrhythmia as a cause of sudden death in hypertrophic cardiomyopathy

13 August 2023

90

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

The 24-hour ambulatory blood pressure profile with verapamil

13 August 2023

91

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Iproveratril: a nonspecific antagonist of peripheral vascular reactivity.

13 August 2023

93

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Short- and long-term efficacy of a calcium-antagonistic agent (nifedipine) combined with methyldopa in the treatment of severe hypertension

13 August 2023

94

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Nifedipine, a new antihypertensive with rapid action

13 August 2023

95

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Acceleration of the ventricular response during atrial fibrillation in the Wolff-Parkinson-White syndrome after verapamil

13 August 2023

96

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Prevention of nifedipine of abnormal coronary vasoconstriction in patients with coronary artery disease

13 August 2023

97

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Inappropriate coronary vasoconstriction in patients with coronary artery disease: A role for nifedipine?

13 August 2023

98

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Effects of verapamil on supraventricular tachycardia in patients with overt and concealed Wolff-Parkinson-White syndrome

13 August 2023

100

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Prognosis and mortality of hypertrophic obstructive cardiomyopathy

13 August 2023

102

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Differential effects of adenosine and nitroglycerin on the action potentials of large and small coronary arteries

13 August 2023

103

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

EFFECTS OF BETA ADRENERGIC BLOCKADE ON THE CIRCULATION WITH PARTICULAR REFERENCE TO OBSERVATIONS IN PATIENTS WITH HYPERTROPHIC SUBAORTIC STENOSIS

13 August 2023

104

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Comparison of verapamil and practolol in paroxysmal supraventricular tachycardia

13 August 2023

105

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Cardiohemodynamic effects of BAY a 1040 in the dog

13 August 2023

106

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Comparative pharmacology of calcium antagonists: Nifedipine, verapamil and diltiazem

13 August 2023

112

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Effect of nifedipine on myocardial ischemia: analysis of collateral flow, pulsatile heat and regional muscle shortening

13 August 2023

113

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Nifedipine therapy for refractory coronary arterial spasm

13 August 2023

114

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Simultaneous assessment of effects of coronary vasodilators on the coronary blood flow and the myocardial contractility by using the blood-perfused canine papillary muscle

13 August 2023

115

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Antihypertensive effect of nifedipine on conscious renal-hypertensive dogs

13 August 2023

116

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

The effects of diltiazem (CRD-401) on the membrane and mechanical properties of vascular smooth muscles of the rabbit

13 August 2023

117

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Efficacy of diltiazem in angina on effort: a multicenter trial

13 August 2023

121

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Divergent effects of diltiazem in patients with exertional angina

13 August 2023

122

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Three cases of severe verapamil poisoning

13 August 2023

123

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Effects of diltiazem Hydrochloride (CRD-401) on renal hemodynamics of dogs

13 August 2023

125

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Production of ischaemic cardiac pain by nifedipine

13 August 2023

127

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Comparison of myocardial preservation with hypothermic potassium and nifedipine arrest

13 August 2023

128

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

A controlled trial of verapamil for Prinzmetal's variant angina

13 August 2023

129

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Comparison of verapamil and nifedipine in the treatment of variant angina pectoris: preliminary observations in 10 patients

13 August 2023

130

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Double-blind, randomized, placebo-controlled comparison of propranolol and verapamil in the treatment of patients with stable angina pectoris

13 August 2023

131

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Induced vasodilation as treatment for Raynaud's disease

13 August 2023

132

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Comparative effects of oral verapamil and propranolol on exercise-induced myocardial ischemia and energetics in patients with coronary artery disease: single-blind placebo crossover evaluation using radionuclide ventriculography

13 August 2023

133

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Nifedipine and left ventricular function in beta-blocked patients

13 August 2023

134

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Nifedipine and Raynaud's phenomenon.

13 August 2023

135

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Treatment of hypertrophic obstructive cardiomyopathy with verapamil, a calcium antagonist (author's transl)

13 August 2023

137

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Treatment of hypertrophic obstructive cardiomyopathy with verapamil

13 August 2023

138

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Primary pulmonary hypertension: beneficial therapy with diltiazem

13 August 2023

139

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Lack of protection of ischemic myocardium by verapamil in conscious dogs

13 August 2023

140

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Contractile proteins of the heart

13 August 2023

141

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Cellular calcium and cardiac cell death

13 August 2023

142

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Prevention of ventricular fibrillation induced by coronary ligation

13 August 2023

143

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Comparative effects of three calcium antagonists, diltiazem, verapamil and nifedipine, on the sinoatrial and atrioventricular nodes. Experimental and clinical studies

13 August 2023

144

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Verapamil protein binding in patients and in normal subjects

13 August 2023

145

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Treatment of variant angina with drugs: a survey of 11 cardiology institutes in Japan

13 August 2023

147

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Suppression of repeatedly occurring ventricular fibrillation with nifedipine in variant form of angina pectoris

13 August 2023

149

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

The Beneficial Effects of Verapamil in Chronic Atrial Fibrillation

13 August 2023

152

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

The influence of verapamil on serum digoxin concentration

13 August 2023

153

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

The acute hemodynamic effects of intravenous verapamil in coronary artery disease. Assessment by equilibrium-gated radionuclide ventriculography

13 August 2023

154

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Inhibition of the slow inward current by nifedipine in mammalian ventricular myocardium

13 August 2023

156

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Pharmacokinetics and bioavailability of diltiazem (CRD-401) in dog

13 August 2023

157

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Verapamil in the treatment of paroxysmal supraventricular tachycardia

13 August 2023

159

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Calcium-channel blockers and beta blockers: Advantages and disadvantages of combination therapy in chronic stable angina pectoris

13 August 2023

160

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Verapamil in the treatment of PSVT.

13 August 2023

161

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

A study on the effects of nifedipine in hypertensive crises and severe hypertension

13 August 2023

163

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Verapamil and Pulmonary Hypertension

13 August 2023

164

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Haemodynamic effects of nifedipine and propranolol in patients with hypertrophic obstructive cardiomyopathy

13 August 2023

165

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Superiority of oral verapamil therapy to digoxin in treatment of chronic atrial fibrillation

13 August 2023

166

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Heart: excitation-contraction coupling

13 August 2023

167

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Does verapamil have a clinically significant antihypertensive effect?

13 August 2023

168

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Acute and chronic effects of nifedipine in arterial hypertension

13 August 2023

169

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Double-blind Evaluation of Verapamil, Propranolol, and Isosorbide Dinitrate against a Placebo in the Treatment of Angina Pectoris

13 August 2023

174

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Modification of abnormal left ventricular diastolic properties by nifedipine in patients with hypertrophic cardiomyopathy

13 August 2023

175

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Acute hemodynamic responses to sublingual nifedipine: dependence on left ventricular function

13 August 2023

177

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Acute hemodynamic effects of nifedipine in patients with ischemic heart disease

13 August 2023

180

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Electrophysiologic and hemodynamic effects of verapamin. Correlation with plasma drug concentrations

13 August 2023

181

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Transient transmural reduction of myocardial blood flow demonstrated by thallium-201 scintigraphy, as a cause of variant angina

13 August 2023

182

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Coronary vasospasm in angina pectoris

13 August 2023

183

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

"Variant" angina: one aspect of a continuous spectrum of vasospastic myocardial ischemia. Pathogenetic mechanisms, estimated incidence and clinical and coronary arteriographic findings in 138 patients

13 August 2023

184

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Significance of spasm in the pathogenesis of ischemic heart disease

13 August 2023

185

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Hemodynamic effects of sublingual nifedipine in congestive heart failure

13 August 2023

187

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Oral verapamil for paroxysmal supraventricular tachycardia: a long-term, double-blind randomized trial

13 August 2023

188

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Clinical pharmacology of slow channel blocking agents

13 August 2023

189

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Arrhythmia in hypertrophic cardiomyopathy: Exercise and 48 hour ambulatory electrocardiographic assessment with and without beta adrenergic blocking therapy

13 August 2023

192

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Short-term efficacy of oral verapamil in rest angina. A double-blind placebo controlled trial in CCU patients

13 August 2023

194

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Metabolic Fate of <I>d-cis</I>-3-Acetoxy-5-[2-(dimethylamino) ethyl]-2, 3-dihydro-2-(<I>p</I>-methoxyphenyl)-1, 5-benzothiazepin-4 (5H)-one Hydrochloride (CRD-401)

13 August 2023

195

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Differential cardiovascular effects of calcium channel blocking agents: potential mechanisms

13 August 2023

196

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Comparative clinical electrophysiologic effects of diltiazem, verapamil and nifedipine: a review

13 August 2023

198

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Intracardiac electrophysiologic study of intravenous diltiazem and combined diltiazem-digoxin in patients

13 August 2023

199

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Nifedipine therapy for stable angina pectoris: Preliminary results of effects on angina frequency and treadmill exercise response

13 August 2023

203

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Reflex Increase in Coronary Vascular Resistance in Patients with Ischemic Heart Disease

13 August 2023

204

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Nifedipine therapy for Prinzmetal's angina

13 August 2023

205

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Studies on a new 1, 5-benzothiazepine derivative (CRD-401). II. Vasodilator actions

13 August 2023

206

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Effects of diltiazem, a calcium antagonist, on regional myocardial function and mitochondria after brief coronary occlusion

13 August 2023

207

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Diltiazem-induced decrease of exercise-elevated pulmonary arterial diastolic pressure in hypertrophic cardiomyopathy patients

13 August 2023

208

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

On the mechanism underlying the action of D-600 on slow inward current and tension in mammalian myocardium

13 August 2023

211

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Protective effect of pretreatment with verapamil, nifedipine and propranolol on mitochondrial function in the ischemic and reperfused myocardium

13 August 2023

212

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Double blind evaluation of orally administered iproveratril in patients with angina pectoris

13 August 2023

213

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Effects of atrio-ventricular conduction of calcium-antagonistic coronary vasodilators, local anaesthetics and quinidine injected into the posterior and the anterior septal artery of the atrio-ventricular node preparation of the dog.

13 August 2023

214

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction

13 August 2023

215

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Coronary arterial spasm in Prinzmetal angina. Documentation by coronary arteriography

13 August 2023

216

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Treatment of hypertension with nifedipine, a calcium antagonistic agent

13 August 2023

217

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Adverse interaction between nifedipine and beta-blockade.

13 August 2023

220

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Management of unstable angina at rest by verapamil. A double-blind cross-over study in coronary care unit

13 August 2023

222

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Comparative effects of nitroglycerin, nifedipine and metoprolol on regional left ventricular function in patients with one-vessel coronary disease

13 August 2023

224

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Pharmacokinetics of diltiazem in selected animal species and human beings

13 August 2023

225

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Verapamil versus placebo in relieving stable angina pectoris

13 August 2023

226

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Clinical use of a calcium antagonistic agent (nifedipine) in acute pulmonary edema

13 August 2023

227

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Effects of verapamil on supraventricular tachycardia in children

13 August 2023

228

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Treatment of angina at rest with nifedipine: a short-term controlled study

13 August 2023

230

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Comparison of the antithrombotic action of calcium antagonist drugs with dipyridamole in dogs

13 August 2023

232

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Relationship of antiarrhythmic to inotropic activity and antiarrhythmic qualities of the optical isomers of verapamil

13 August 2023

235

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Differences in the cardiac actions of the calcium antagonists verapamil and nifedipine

13 August 2023

236

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

The Effect of a Calcium-antagonistic Drug, Nifedipine, on the Mechanical and Electrical Activity of the Isolated Rat Atrium

13 August 2023

239

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Effect of the calcium antagonist verapamil on necrosis following temporary coronary artery occlusion in dogs

13 August 2023

240

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Properties of Two Inward Membrane Currents in the Heart

13 August 2023

241

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Effects of intravenous and chronic oral verapamil administration in patients with supraventricular tachyarrhythmias

13 August 2023

243

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Efficacy of diltiazem for control of symptoms of coronary arterial spasm

13 August 2023

244

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. I. Hemodynamic effects

13 August 2023

246

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Cardiovascular actions of iproveratril

13 August 2023

247

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Mechanism of relief of pacing induced angina with oral verapamil: reduced oxygen demand

13 August 2023

248

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Effect of nifedipine on atrioventricular conduction as compared with verapamil. Intracardiac electrophysiological study

13 August 2023

249

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Electrophysiologic effects of diltiazem hydrochloride on supraventricular tachycardia

13 August 2023

250

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Electrophysiology and Antiarrhythmic Effects of Calcium Antagonists

13 August 2023

251

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

A double-blind randomized trial of propranolol and verapamil in the treatment of effort angina

13 August 2023

253

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Clinical evaluation of verapamil in angina pectoris.

13 August 2023

255

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Immediate effects of intravenous verapamil on atrial fibrillation

13 August 2023

256

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Randomized withdrawal from nifedipine: placebo-controlled study in patients with coronary artery spasm

13 August 2023

257

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

The pharmacodynamics of orally taken verapamil and verapamil retard as judged by their negative dromotropic effects

13 August 2023

258

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Physiological disposition of verapamil in man

13 August 2023

261

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Multiclinic controlled trial of diltiazem for Prinzmetal's angina

13 August 2023

262

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Acute and chronic pharmacodynamic interaction of verapamil and digoxin in atrial fibrillation

13 August 2023

263

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Hemodynamic effects of verapamil and practolol in man

13 August 2023

264

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

The effects of nifedipine on acute experimental myocardial ischemia and infarction in dogs

13 August 2023

265

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Reduced verapamil clearance during long-term oral administration

13 August 2023

267

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Myocardial calcium and magnesium in acute ischemic injury

13 August 2023

268

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Inhibition of Hypoxic Pulmonary Vasoconstriction by Nifedipine

13 August 2023

269

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Effect of nifedipine (Adalat) on coronary haemodynamics in patients with coronary arteriosclerotic disease

13 August 2023

271

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Effects of intravenous verapamil on hemodynamics in patients with heart disease

13 August 2023

273

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

A fourth class of anti-dysrhythmic action? Effect of verapamil on ouabain toxicity, on atrial and ventricular intracellular potentials, and on other features of cardiac function

13 August 2023

274

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

New perspectives in the pharmacologic therapy of cardiac arrhythmias

13 August 2023

275

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Verapamil: a review of its pharmacological properties and therapeutic use.

13 August 2023

276

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Calcium antagonists. Clinical use in the treatment of arrhythmias

13 August 2023

277

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Electrophysiologic and hemodynamic effects of slow-channel blocking drugs

13 August 2023

279

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Controlled trial of nifedipine in the treatment of Raynaud's phenomenon

13 August 2023

281

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Regional contractility. Selective depression of ischemic myocardium by verapamil

13 August 2023

282

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Hemodynamic effects of verapamil in children and adolescents with hypertrophic cardiomyopathy

13 August 2023

283

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Calcium channel blocking agents in the treatment of cardiovascular disorders. Part II: Hemodynamic effects and clinical applications

13 August 2023

285

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Safety and efficacy of diltiazem hydrochloride for the treatment of stable angina pectoris: report of a cooperative clinical trial

13 August 2023

286

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Electrophysiologic effects of diltiazem, a calcium antagonist, in patients with impaired sinus or atrioventricular node function

13 August 2023

287

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Verapamil. A new class of antiarrhythmic agents with a variety of beneficial cardiovascular effects

13 August 2023

290

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Nifedipine therapy in angina pectoris: evaluation of safety and side effects

13 August 2023

291

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Protective action of calcium channel antagonist agents against ventricular fibrillation in the isolated perfused rat heart

13 August 2023

292

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Provocative testing with ergonovine to evaluate the efficacy of treatment with calcium antagonists in variant angina

13 August 2023

293

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Verapamil in Prophylaxis of Paroxysmal Atrioventricular Nodal Reentrant Tachycardia

13 August 2023

294

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Selectivity of calcium antagonistic action in vascular smooth muscle

13 August 2023

299

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Calcium channel blockers and Raynaud's disease

13 August 2023

302

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Effect of nifedipine on segmental myocardial function in the anesthetized pig.

13 August 2023

303

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Myocardial protection through cold cardioplegia with potassium or diltiazem. Experimental evidence that diltiazem provides better protection even when coronary flow is impaired by a critical stenosis

13 August 2023

305

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Verapamil for control of ventricular rate in paroxysmal supraventricular tachycardia and atrial fibrillation or flutter: a double-blind randomized cross-over study

13 August 2023

307

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Calcium accumulation and enzymatic activities of subcellular fractions from aortas and ventricles of genetically hypertensive rats

13 August 2023

308

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Effect of diltiazem, a calcium antagonist, on myocardial ischemia

13 August 2023

309

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Effect of procainamide, propranolol and verapamil on mechanism of tachycardia in patients with chronic recurrent ventricular tachycardia

13 August 2023

311

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Triggered activity in cardiac muscle fibers of the simian mitral valve

13 August 2023

313

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Triggered and automatic activity in the canine coronary sinus

13 August 2023

314

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Verapamil disposition in liver disease and intensive-care patients: kinetics, clearance, and apparent blood flow relationships

13 August 2023

315

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Effects of oral verapamil in patients with atrioventricular reentrant tachycardia incorporating an accessory pathway

13 August 2023

316

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

"Calcium Influx Blockers" and Vascular Smooth Muscle: Do We Really Understand the Mechanisms?

13 August 2023

318

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

The pharmacokinetics of diltiazem in healthy American men

13 August 2023

319

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

Calcium kinetics in the aorta of spontaneously hypertensive rats

13 August 2023

320

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90025-6

13 August 2023

Identifiers

1 reference

17 September 2017

1 reference